<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">B-cell-specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Gero</forename><surname>Knittel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department I of Internal Medicine</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><surname>Liedgens</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department I of Internal Medicine</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Darya</forename><surname>Korovkina</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department I of Internal Medicine</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jens</forename><forename type="middle">M</forename><surname>Seeger</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Institute for Microbiology and Hygiene</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yussor</forename><surname>Al-Baldawi</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Radiology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mona</forename><surname>Al-Maarri</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Max Planck Institute for Metabolism Research</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Fritz</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department I of Internal Medicine</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katerina</forename><surname>Vlantis</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Svetlana</forename><surname>Bezhanova</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="laboratory">N.N. Blokhin Russian Cancer Research Center</orgName>
								<address>
									<settlement>Moscow</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">H</forename><surname>Scheel</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Olaf-Oliver</forename><surname>Wolz</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Interfaculty Institute for Cell Biology</orgName>
								<orgName type="department" key="dep2">Department of Immunology</orgName>
								<orgName type="institution">University of Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maurice</forename><surname>Reimann</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Hematology/Oncology</orgName>
								<orgName type="institution">Charité-University Medical Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cristina</forename><forename type="middle">L</forename><surname>Ópez</surname></persName>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Institute of Pathology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Ulm University</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution" key="instit1">Institute for Human Genetics</orgName>
								<orgName type="institution" key="instit2">Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><surname>Schlesner</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of Theoretical Bioinformatics</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philipp</forename><surname>Lohneis</surname></persName>
							<affiliation key="aff13">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">Charité-University Medical Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><forename type="middle">N R</forename><surname>Weber</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Interfaculty Institute for Cell Biology</orgName>
								<orgName type="department" key="dep2">Department of Immunology</orgName>
								<orgName type="institution">University of Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lorenz</forename><surname>Tr</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Louis</forename><forename type="middle">M</forename><surname>Staudt</surname></persName>
							<affiliation key="aff15">
								<orgName type="department" key="dep1">Metabolism Branch</orgName>
								<orgName type="department" key="dep2">Center for Cancer Research</orgName>
								<orgName type="institution" key="instit1">National Cancer Institute</orgName>
								<orgName type="institution" key="instit2">National Institutes of Health</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Monika</forename><surname>Ortmann</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manolis</forename><surname>Pasparakis</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Reiner</forename><surname>Siebert</surname></persName>
							<affiliation key="aff11">
								<orgName type="institution" key="instit1">Institute for Human Genetics</orgName>
								<orgName type="institution" key="instit2">Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clemens</forename><forename type="middle">A</forename><surname>Schmitt</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Department of Hematology/Oncology</orgName>
								<orgName type="institution">Charité-University Medical Center</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff16">
								<orgName type="department">Max Delbrück Center for Molecular Medicine</orgName>
								<orgName type="institution">Helmholtz Association</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">R</forename><surname>Klatt</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Institute for Clinical Chemistry</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><forename type="middle">Thomas</forename><surname>Wunderlich</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Max Planck Institute for Metabolism Research</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephan</forename><forename type="middle">C</forename><surname>Sch</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Institute of Pathology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thorsten</forename><surname>Persigehl</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Radiology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Montesinos-Rongen</surname></persName>
							<affiliation key="aff18">
								<orgName type="department">Institute of Neuropathology</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">German International Cancer Genome Consortium Molecular Mechanisms in Malignant Lymphoma by Sequencing Project Consortium</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">Department of Hematology and Oncology</orgName>
								<orgName type="institution">Georg-August University</orgName>
								<address>
									<settlement>Goettingen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department">Center of Integrated Oncology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department">Center of Molecular Medicine</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">B-cell-specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">E39EBFD57590DF486D231B3B0C5851B1</idno>
					<idno type="DOI">10.1182/blood-2015-11-</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>B-cell-specific expression of Myd88 p.L252P leads to the development of DLBCL in mice.</s></p><p><s>• The Myd88 p.L252P mutation cooperates with BCL2 amplifications in ABC-DLBCL lymphomagenesis in vivo.</s></p><p><s>The adaptor protein MYD88 is critical for relaying activation of Toll-like receptor signaling to NF-kB activation.</s><s>MYD88 mutations, particularly the p.L265P mutation, have been described in numerous distinct B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL).</s><s>Twenty-nine percent of activated B-cell-type DLBCL (ABC-DLBCL), which is characterized by constitutive activation of the NF-kB pathway, carry the p.L265P mutation.</s><s>In addition, ABC-DLBCL frequently displays focal copy number gains affecting BCL2.</s><s>Here, we generated a novel mouse model in which Cre-mediated recombination, specifically in B cells, leads to the conditional expression of Myd88 p.L252P (the orthologous position of the human MYD88 p.L265P mutation) from the endogenous locus.</s><s>These mice develop a lymphoproliferative disease and occasional transformation into clonal lymphomas.</s><s>The clonal disease displays the morphologic and immunophenotypical characteristics of ABC-DLBCL.</s><s>Lymphomagenesis can be accelerated by crossing in a further novel allele, which mediates conditional overexpression of BCL2.</s><s>Cross-validation experiments in human DLBCL samples revealed that both MYD88 and CD79B mutations are substantially enriched in ABC-DLBCL compared with germinal center B-cell DLBCL.</s><s>Furthermore, analyses of human DLBCL genome sequencing data confirmed that BCL2 amplifications frequently cooccurred with MYD88 mutations, further validating our approach.</s><s>Finally, in silico experiments revealed that MYD88-mutant ABC-DLBCL cells in particular display an actionable addiction to BCL2.</s><s>Altogether, we generated a novel autochthonous mouse model of ABC-DLBCL that could be used as a preclinical platform for the development and validation of novel therapeutic approaches for the treatment of ABC-DLBCL.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Toll-like receptors (TLRs) belong to a class of pattern-recognition receptors. <ref type="bibr" target="#b0">1</ref></s><s>Ten distinct human TLRs have been described. <ref type="bibr" target="#b0">1</ref></s><s>Except for TLR3, all TLRs require the adaptor protein MYD88 to initiate downstream signaling. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>Upon TLR activation, MYD88 is recruited to the Toll/interleukin-1 receptor (TIR) domain of the activated TLR via its own TIR domain. <ref type="bibr" target="#b2">3</ref></s><s>MYD88 recruits IRAK1, -2, and -4 to ultimately Submitted November 30, 2015; accepted March 30, 2016.</s><s>Prepublished online as Blood First Edition paper, April 5, 2016; DOI 10.1182/blood-2015-11-684183.</s><s>*G.K., P.L., D.K., and J.M.S. contributed equally to this study.</s><s>†L.P.F., H.K., and H.C.R. contributed equally to this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The online version of this article contains a data supplement.</head><p><s>There is an Inside Blood Commentary on this article in this issue.</s></p><p><s>The publication costs of this article were defrayed in part by page charge payment.</s><s>Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734.</s><s>form the myddosome. <ref type="bibr" target="#b3">4</ref></s><s>IRAK4-mediated phosphorylation of IRAK1 and IRAK2 promotes TRAF6 recruitment, <ref type="bibr" target="#b4">5</ref> which subsequently ubiquitylates and activates TAK1, <ref type="bibr" target="#b5">6</ref> leading to NF-kB activation. <ref type="bibr" target="#b1">2</ref> Inappropriate TLR signaling through somatic MYD88 mutations has been described in numerous hematologic malignancies, such as chronic lymphocytic leukemia (CLL), <ref type="bibr" target="#b6">7</ref> Waldenström macroglobulinemia, <ref type="bibr" target="#b7">8</ref> and diffuse large B-cell lymphoma (DLBCL). <ref type="bibr" target="#b8">9</ref></s><s>Specifically, 29% of activated B-cell-type DLBCLs (ABC-DLBCLs), which typically display constitutive NF-kB activation, carry the p.L265P mutation (position according to the protein accession NP_002459) in the hydrophobic core of the MYD88 TIR domain. <ref type="bibr" target="#b8">9</ref></s><s>ABC-DLBCL was shown to display MYD88 p.L265P -dependent NF-kB activation and STAT3 phosphorylation. <ref type="bibr" target="#b8">9</ref></s><s>The MYD88 p.L265P mutation is exceedingly rare in non-ABC-DLBCLs, such as germinal center B-cell (GCB) and primary mediastinal B-cell lymphoma. <ref type="bibr" target="#b8">9</ref></s><s>Moreover, MYD88 p.L265P -mutant ABC-DLBCL appears to be dependent on continued MYD88 p.L265P expression. <ref type="bibr" target="#b8">9</ref></s><s>Together, these data implicate MYD88-dependent oncogenic NF-kB signaling as an integral contributor to ABC-DLBCL pathogenesis and as a potential therapeutic target.</s><s>However, despite the clinical relevance of the MYD88 p.L265P mutation, no autochthonous mouse model that faithfully mimics this critical genomic aberration has yet been generated.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p><s>Experimental mice B-cell-specific Cre expression was achieved by using Cd19 Cre , <ref type="bibr" target="#b9">10</ref> Aid Cre , <ref type="bibr" target="#b10">11</ref> and Cd21 Cre12 deleter mouse strains (The Jackson Laboratory).</s><s>The targeting vector depicted in Figure <ref type="figure">1A</ref> was constructed by using standard techniques.</s><s>The gene targeting strategy was based on the National Center for Biotechnology Information transcript NM_010851.2 in which exon 1 contains the translation initiation codon.</s><s>Wild-type (wt) exons 2-6, including the entire 39 untranslated region were flanked with LoxP sites.</s><s>An additional polyadenylation signal (human growth hormone polyadenylation [hGHpA] signal) has been inserted between the 39 untranslated region and the distal LoxP site to prevent downstream transcription of the mutated exon 5.</s><s>The size of the LoxP-flanked region is 4.7 kb.</s><s>Exons 2-6, including the splice acceptor site of intron 1, have been duplicated and inserted downstream of the distal LoxP site.</s><s>The p.L252P mutation has been introduced into the duplicated exon 5. Positive selection markers were flanked by Frt (neomycin resistance; Neo R ) and F3 (puromycin resistance; Puro R ) sites and inserted into intron 1 and downstream of the hGHpA, respectively.</s><s>The targeting vector was generated by using BAC clones from the C57BL/6J RPCIB-731 BAC library and was transfected into the C57BL/6N Tac embryonic stem (ES) cell line.</s><s>Targeted clones were isolated by using double positive (Neo R and Puro R ) selection, and correct integration was verified by Southern blotting.</s><s>Upon blastocyst injection, germ line-transmitting transgenic mice were received.</s><s>The conditional Myd88 c-p.L252P allele was obtained after in vivo Flp-mediated removal of the selection markers.</s><s>This allele expresses the wild-type Myd88 protein, because the presence of the hGHpA cassette downstream of wildtype exon 6 prevents transcription of the mutant exons 2-6.</s><s>The constitutive Myd88 p.L252P allele is obtained after in vivo Cre-mediated deletion of wild-type exons 2-6 and hGHpA.</s><s>This allele expresses the mutant Myd88 L252P protein.</s><s>The remaining recombination sites are located in nonconserved regions of the genome.</s><s>To generate conditional BCL2 knockin mice (Rosa26 LSL.BCL2.IRES.GFP ), a Rosa26 locus-targeting vector was used in which CAGS (cytomegalovirus early enhancer/chicken b actin) promoterdriven expression of the transgene (BCL2) and downstream expression of an internal ribosomal entry site-driven green fluorescent protein (IRES-GFP, as a reporter for Cre-mediated recombination) is prevented by a LoxP-flanked STOP cassette (supplemental Figure <ref type="figure">5C</ref>, available on the Blood Web site).</s><s>The transgenic mice expressed the transgenes only after Cre-mediated excision of the LoxP-flanked STOP cassette.</s><s>The targeting vector was electroporated into ES cells (BRUCE4), which were screened for correct integration by standard Southern blot methods.</s><s>Correctly targeted ES cells were used to generate chimeras, which were backcrossed onto a pure C57BL/6N background and examined for germ line transmission.</s></p><p><s>The Em:Myc model has been described earlier and was used, as previously described. <ref type="bibr" target="#b12">13</ref></s><s>The Em:Tcl1 model of CLL was described earlier. <ref type="bibr" target="#b13">14</ref></s><s>All the experiments that involved the breeding and/or treatment of rodents were approved by the local animal care committee and the relevant authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, AZ: 84-02.04.2014.A146/A083).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transplantation experiments</head><p><s>Animal protocols based on the Em:Myc transgenic mouse model as used in this study were approved by the local governmental review board (Landesamt Berlin) and conformed to regulatory standards.</s><s>Isolation, retroviral infection, transplantation of Em:Myc transgenic fetal liver cells (ie, hematopoietic stem cells), and subsequent monitoring of the recipient mice regarding lymphoma onset were performed as previously described. <ref type="bibr" target="#b14">15</ref></s><s>Specifically, numerous independently isolated fetal liver cell populations were stably transduced with a murine stem cell virus-based Myd88 p.L252P-IRES-GFP retrovirus or a murine stem cell virus-empty GFP construct as a control before their propagation in recipient mice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry</head><p><s>Formalin-fixed paraffin-embedded (FFPE) murine samples were sliced at 2 to 4 mm.</s><s>Sections were stained with hematoxylin and eosin (H&amp;E) and antibodies against Ki-67 (Cell Marque), B220 (RA3-6B2BD,), p65 (C-20; Santa Cruz,), Irf4 (M-17; Santa Cruz Biotechnology,), Bcl6 (C-19; Santa Cruz Biotechnology), and Cd138 (553712; BD).</s><s>Staining intensities were scored by 2 independent observers who used a 4-tier scale.</s><s>FFPE human samples were sliced at 2 to 4 mm.</s><s>Sections were stained with H&amp;E and antibodies against CD10 (NCL-L-CD10-270; Novocastra), BCL6 (M7211; Dako), IRF4 (M7259; Dako), BCL2 (M0877; Dako), and CD138 (138M-16; Cell Marque).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Sequence analysis of immunoglobulin genes and cloning of polymerase chain reaction products</head><p><s>RNA was extracted from sections of frozen biopsies with TRI Reagent (Sigma, Taufkirchen, Germany).</s><s>One microgram of RNA was converted to complementary DNA with QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany).</s><s>Mouse IgH rearrangements were analyzed by using previously published methods. <ref type="bibr" target="#b15">16</ref></s><s>Each polymerase chain reaction (PCR) was analyzed on a Qiaxcel Advanced Instrument (Qiagen) by using ScreenGel Software v1.2.</s><s>Direct sequencing was performed with the ABI Prism Dye Terminator Cycle Sequencing Ready Reaction Kit v3.1 (Life Technologies, Darmstadt, Germany) on an ABI 3130 sequencer (Applied Biosystems, Foster City, CA).</s><s>Sequences were analyzed by using 4Peaks Software v1.7.2 (The Netherlands Cancer Institute, Amsterdam, The Netherlands), Lasergene software (DNAStar, Madison, WI), and by manual review.</s><s>Sequences were compared with mouse germ line Ig gene sequences with International ImMunoGeneTics database. <ref type="bibr" target="#b16">17</ref></s><s>In addition, the PCR products of 1 case were cloned with the TOPO TA Cloning Kit (Life Technologies), which resulted in 32 sequences.</s><s>To generate genealogic trees, sequence analysis focused on the IGHV segment, starting within FR1.</s><s>To exclude possible Taq errors, only mutations shown more than once were considered for analysis (see supplemental Data).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>To assess the role of MYD88 p.L265P in B-cell lymphomagenesis, we generated a conditional Myd88 p.L252P allele (Myd88 c-p.L252P ) that is expressed from the endogenous locus upon Cre-mediated recombination (Figure <ref type="figure">1A</ref>).</s><s>Murine Myd88 p.L252P is at the orthologous position of human Myd88 p.L265P .</s><s>To verify Cre-inducible Myd88 p.L252P expression, we derived murine embryonic fibroblasts (MEFs) from wild-type and Myd88 c-p.L252P/c-p.L252P mice.</s><s>By using Sanger sequencing, we detected expression of Myd88 wt messenger RNA (mRNA) in both Myd88 wt/wt and Myd88 c-p.L252P/c-p.L252P MEFs, indicating lack of background expression of Myd88 p.L252P in the absence of Cre recombinase.</s><s>In contrast, cytomegalovirus promoter-driven Cre expression mediated by lentiviral transduction of Myd88 c-p.L252P/c-p.L252P MEFs induced recombination in the Myd88 locus, leading to expression of Myd88 p.L252P -mutant mRNA (Figure <ref type="figure">1B</ref>).</s><s>Myd88 protein abundance was unaffected by stable Cre expression, indicating that the Myd88 p.L252P isoform is expressed at endogenous levels (Figure <ref type="figure">1C</ref>).</s><s>This Myd88 p.L252P expression translated into robust p65 Ser-536 phosphorylation, indicating activation of NF-kB signaling (Figure <ref type="figure">1D</ref>).</s></p><p><s>To determine whether B-cell-specific Myd88 p.L252P expression promotes lymphomagenesis, we compared Cd19 Cre/wt ;Myd88 c-p.L252P/wt (hereafter M-Cd19) and Cd19 Cre/wt (hereafter Cd19) mice.</s><s>The mice were longitudinally monitored by magnetic resonance imaging (MRI).</s><s>Although no gross lymphoproliferative disease (LPD) was detectable in Cd19 mice, M-Cd19 mice developed splenomegaly and occasional lymphadenopathy starting at the age of ;60 weeks (Figure <ref type="figure">2B</ref>).</s><s>Similar MRI morphologic signs of LPD were observed when B-cell-specific Myd88 p.L252P expression was induced by Cre Arg Cre    expression that was driven off the Aid promoter (hereafter M-Aid), which is active in GCB cells, during both T cell-dependent and -independent immune responses (supplemental Figure <ref type="figure">1A</ref>). <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b17">18</ref></s><s>urthermore, Cd21 promoter-driven Cre, which is expressed when immature transitional B cells differentiate into mature long-lived peripheral B cells, <ref type="bibr" target="#b11">12</ref> induced an LPD in Cd21 Cre/wt ;Myd88 c-p.L252P/wt mice (hereafter M-Cd21) that was indistinguishable from that observed in M-Cd19 mice (supplemental Figure <ref type="figure">1A</ref>).</s><s>The MRI morphologic occurrence of lymphoproliferative lesions translated into a significantly (P 5 .0075)</s><s>reduced overall survival of M-Cd19 mice (median survival, 501 days) compared with Cd19 mice (median survival, not reached in 10 mice observed for 427 to 581 days [average, 539 days]) (Figure <ref type="figure">2A</ref>).</s><s>Similar data were obtained when Cre expression was driven off the Aid or Cd21 promoter in M-Aid and M-Cd21 mice (median survival, 574 and 610 days, respectively) (supplemental Figure <ref type="figure">1B</ref>).</s><s>We noted that the majority of M-Cd19, M-Aid, and M-Cd21 mice included in this study displayed splenomegaly (4 of 4, M-Cd19; 2 of 3, M-Aid; and 2 of 3, M-Cd21), occasionally accompanied by macroscopic lymphadenopathy (1 of 4, M-Cd19; 2 of 3, M-Aid; and 1 of 3, M-Cd21).</s><s>The strong oncogenic potential of the Myd88 p.L252P mutation was also verified in an alternative mouse model of aggressive B-cell lymphoma in which Myd88 p.L252P dramatically shortened tumor onset driven by oncogenic Myc (Em:Myc transgenic fetal liver cells transplanted into lethally irradiated recipient mice, stably transduced with either empty vector [n 5 40; median onset not reached] or Myd88 p.L252P [n 5 12; median onset, 36 days]; log-rank Mantel-Cox P , .0001)</s><s>(supplemental Figure <ref type="figure">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Myd88 wt/wt</head><formula xml:id="formula_0">C C G G T T T A A C C G G T T T A A C C G G C T T A A</formula><p><s>To characterize the disease occurring in M-Cd19 mice, we initially performed histologic examinations.</s><s>H&amp;E staining of spleens and livers of M-Cd19, M-Aid, and M-Cd21 mice revealed infiltrates of lymphoid cells in these organs.</s><s>In particular, the architecture of the spleens of these mice was largely disrupted by these infiltrates (4 of 4, M-Cd19; 3 of 3, M-Aid; 3 of 3, M-Cd21).</s><s>Of note, we did not detect any infiltration of the bone marrow (n 5 3 per genotype; supplemental Figure <ref type="figure">3</ref>).</s><s>Further analyses of the splenic and hepatic infiltrates revealed that these lesions constituted a largely monomorphic lymphoid cell population with indolent appearance, consistent with an LPD.</s><s>Intriguingly, in a subset of mice (1 of 4, M-Cd19; 1 of 3, M-Aid; and 1 of 3, M-Cd21), diffuse large lymphoid infiltrates resembling DLBCL were detectable (Figure <ref type="figure">2D</ref>; supplemental Figure <ref type="figure">1D-E</ref>).</s><s>Of note, the Ki-67 indices did not substantially differ between areas with LPD and DLBCL morphology (Figure <ref type="figure">2D</ref>).</s><s>To determine the clonality of these infiltrates, we next performed Southern blot analyses to detect clonal immunoglobulin (Ig) rearrangements.</s><s>We were not able to detect clonal Ig rearrangements in genomic DNA isolated from areas with LPD-like appearance that were detected in M-Cd19, M-Aid, and M-Cd21 mice (supplemental Figure <ref type="figure">4A</ref>).</s><s>Strikingly, oligoclonal Ig rearrangement patterns were detected in DNA isolated from infiltrates that displayed DLBCL-like morphology in M-Cd19, M-Aid, and M-Cd21 mice (indicated by white triangles in supplemental Figure <ref type="figure">4A</ref>).</s><s>DNA isolated from spleens of an Em:Tcl1-driven CLL mouse model served as a positive control for the development of a clonal lymphoid neoplasm. <ref type="bibr" target="#b13">14</ref></s><s>Altogether, our data strongly indicate that B-cell-specific Myd88 c-p.L252P expression largely leads to an LPD, with only occasional development of mono-/oligoclonal lymphoma.</s></p><p><s>To further characterize the LPD and lymphomas, we next performed immunohistochemistry in liver infiltrates of M-Cd19 mice.</s><s>As shown in Figure <ref type="figure">2E</ref>, the areas with DLBCL-like morphology displayed a strikingly uniform staining pattern.</s><s>These lesions were B220 and Irf4 positive and were Bcl6 and Cd138 negative, resembling the immunophenotype of a post-GCB lymphoid malignancy. <ref type="bibr" target="#b18">19</ref></s><s>In contrast, the areas of LPD displayed a rather heterogeneous staining pattern for B220, Irf4, and Cd138 and were largely negative for Bcl6, further underscoring the nonclonal characteristics of these lesions.</s><s>We noted that areas of LPD and DLBCL-like morphology in M-Aid and M-Cd21 mice displayed similar staining patterns (supplemental Figure <ref type="figure">1F-G</ref>).</s></p><p><s>To further interrogate the nature of the DLBCL-like lesions, we next used immunohistochemistry to assess subcellular NF-kB localization, because constitutive NF-kB activation, indicated by nuclear enrichment, is a hallmark feature of ABC-DLBCL. <ref type="bibr" target="#b8">9</ref></s><s>These experiments revealed a uniform nuclear staining of the NF-kB subunit p65 in the DLBCL-like lesions detected in spleens and livers of M-Cd19, M-Aid, and M-Cd21 mice (Figure <ref type="figure">2F</ref>; supplemental Figure <ref type="figure">1C</ref>).</s><s>Given that ABC-DLBCL, which is characterized by constitutive NF-kB activation, carries the p.L265P mutation in 29% of the cases, <ref type="bibr" target="#b8">9</ref> and given that the clonal lymphoproliferation we observed in M-Cd19 mice displayed morphologic features of DLBCL, we hypothesized that the B-cellspecific Myd88 c-p.L252P expression drives ABC-DLBCL development in our model.</s></p><p><s>To cross-validate our observations, we analyzed MYD88 mutation frequency in human DLBCLs (n 5 24, GCB-DLBCL; n 5 21, ABC-DLBCL).</s><s>We performed targeted sequencing of FFPE-extracted DNA by multiplex PCR covering the MYD88, ATM, BTK, CD79B, DDX3X, FBXW7, MAPK1, NOTCH1, PIK3CA, PIK3CD, PTEN, PTPN6, SF3B1, TP53, and XPO1 genes (Figure <ref type="figure">3A</ref>).</s><s>DLBCL subtypes were determined based on immunohistochemical stains for CD10, BCL6, and IRF4 following the Hans algorithm (Figure <ref type="figure">3B</ref>). <ref type="bibr" target="#b18">19</ref></s><s>The non-GCB of Hans algorithm was designated as "ABC" in our study.</s><s>Confirming previously published data, we found a substantial overrepresentation of MYD88 and CD79B mutations in ABC-DLBCLs compared with GCB-DLBCLs (Figure <ref type="figure">3A</ref>,C; supplemental Table <ref type="table">1</ref>). <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref></s><s>Furthermore, the anti-apoptotic oncogene BCL2 is frequently deregulated in human DLBCL. <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b23">23</ref></s><s>]<ref type="bibr" target="#b24">[24]</ref><ref type="bibr" target="#b25">[25]</ref> Indeed, mining of the whole-genome sequencing data on DLBCL from the German International Cancer Genome Consortium Molecular Mechanisms in Malignant Lymphoma by Sequencing Project (https:// icgc.org/ and C.L., M.S., and R.S., manuscript in preparation) revealed that 6 DLBCLs carry the MYD88 p.L265P mutation.</s><s>Remarkably, all of these samples belonged to the ABC-DLBCL subtype and carried a copy number gain of 18q detected by both fluorescent in situ hybridization with a BCL2-specific probe and somatic copy number variant mapping. <ref type="bibr" target="#b26">26,</ref><ref type="bibr" target="#b27">27</ref></s><s>A critical role for BCL2, particularly in activated B cells, is further corroborated by published transcriptome analyses.</s><s>Specifically, BCL2 mRNA was not expressed in GCB cells but was massively induced during activation of peripheral blood B cells. <ref type="bibr" target="#b28">28</ref></s><s>Consistent with this, the majority of ABC-DLBCLs displayed BCL2 mRNA levels more than fourfold higher than GCB cells. <ref type="bibr" target="#b28">28</ref></s><s>Furthermore, exogenous expression of MYD88 p.L265P in B cells was recently shown to induce the accumulation of self-reactive B cells in vivo only when apoptosis was opposed by Bcl2 overexpression. <ref type="bibr" target="#b29">29</ref></s><s>Additional circumstantial evidence suggesting that ABC-DLBCL in particular might depend on functional BCL2 activity could be derived from recently published, large-scale in vitro drug sensitivity profiling experiments.</s><s>Specifically, re-assessment of a data set published by Stegmeier and colleagues revealed that MYD88-mutant DLBCLs in particular display an actionable BCL2 addiction, which could be exploited by the targeted high-affinity BCL2 inhibitor ABT-263 (supplemental Figure <ref type="figure">5A-B</ref>). <ref type="bibr" target="#b30">30</ref></s><s>The BTK inhibitor ibrutinib was recently shown to synergistically interact with the BCL2 family inhibitor navitoclax (ABT-263) in killing ABC-DLBCL cells. <ref type="bibr" target="#b31">31</ref></s><s>We validated these observations in our cohort of DLBCL samples by using immunohistochemistry to assess BCL2 expression.</s><s>As shown in Figure <ref type="figure">3D-E</ref>, high-level BCL2 expression was significantly enriched in ABC-DLBCL patients compared with patients who had GCB-DLBCL.</s><s>Altogether, these genomic, transcriptomic, immunohistochemical, and functional data strongly suggest that enhanced BCL2 activity plays a central pathomechanistic role in the development of ABC-DLBCL.</s><s>On the basis of these considerations, we next asked whether lymphoma development in M-Cd19 mice could be accelerated by increased BCL2 gene dosage in vivo.</s><s>To mimic BCL2 amplification in vivo, we generated a novel conditional allele in which BCL2.IRES.</s><s>GFP was targeted into the Rosa26 locus.</s><s>BCL2 expression was prevented by the insertion of a LoxP.STOP.LoxP cassette upstream of the translation-initiating codon (supplemental Figure <ref type="figure">5C</ref>).</s><s>By using this allele, we generated Cd19 Cre/wt ;Rosa26 LSL.BCL2.IRES.GFP/wt ;Myd88 c-p.L252P/wt mice (hereafter M-B-Cd19), in which Cd19-driven Cre mediates the excision of the LoxP.STOP.LoxP cassette from the Rosa26 locus, leading to CAGS-promoter-driven BCL2 overexpression in addition to Myd88 p.L252P expression.</s><s>MRI scans revealed that M-B-Cd19 mice developed splenomegaly substantially earlier than M-Cd19, M-Aid, or M-Cd21 mice (Figures <ref type="figure">2B and 4B</ref>; supplemental Figure <ref type="figure">1A</ref>).</s><s>Furthermore, M-B-Cd19 mice displayed a significantly reduced overall survival (median survival, 179 days) compared with M-Cd19, M-Aid, and M-Cd21 mice (long-rank P 5 .0008,</s><s>P 5 .0001,</s><s>and P , .0001,</s><s>respectively) (Figure <ref type="figure">4A</ref>).</s><s>Of note, all of the M-B-Cd19 mice displayed excessive lymphadenopathy and/or splenomegaly at the time of death (splenomegaly in 7 of 8 mice; lymphadenopathy in 6 of 8 mice).</s></p><p><s>To further characterize the nature of the lymphadenopathy that we observed in M-B-Cd19 mice by MRI, we next performed histologic examination of infiltrated organs (livers, lymph nodes, and spleens).</s><s>Morphologic assessment of the splenic, hepatic, and lymph node lesions detected in M-B-Cd19 mice revealed that these infiltrates consisted almost entirely of diffuse large lymphoid cells with blastoid to plasmablastoid appearance (Figure <ref type="figure">4C</ref>).</s><s>Intriguingly, plasmablasts have been implicated as the cell of origin of ABC-DLBCL. <ref type="bibr" target="#b24">24</ref></s><s>In marked contrast to the phenotype observed in M-Cd19 mice, in which the bulk of the lesions consisted of LPD-like infiltrates (Figure <ref type="figure">2D</ref>), areas of LPD were only rarely detectable in M-B-Cd19 mice.</s><s>Furthermore, the Ki-67 index of the lymphoid lesions in M-B-Cd19 mice was significantly higher compared with lesions that emerged in M-Cd19 mice (median, 71.57% 6 3.65% in M-B-Cd19 mice vs 28.27% 6 2.40% in M-Cd19 mice) (Figure <ref type="figure">4F</ref>).</s><s>The Ki-67 indices observed in M-B-Cd19 mice matched those typically detected in aggressive human lymphoma. <ref type="bibr" target="#b32">32</ref></s><s>eukemic effusion was detectable only in M-B-Cd19 mice (supplemental Figure <ref type="figure">6</ref>).</s><s>Consistent with the monomorphic appearance of the blastoid lesions detected in M-B-Cd19 mice, clonality analyses using Southern blot to detect Ig rearrangements revealed that these infiltrates were of clonal or oligoclonal origin (3 of 3 lesions isolated from independent mice) (Figure <ref type="figure">4D</ref>).</s><s>Expression of the mutant Myd88 allele in the lymphomas was verified by reverse transcriptase PCR sequencing analysis (supplemental Figure <ref type="figure">7</ref>).</s><s>To ask whether the oligoclonal lymphomas underwent somatic hypermutation, as would be expected in the case of ABC-DLBCL, we analyzed a clonal lesion for Igh rearrangements by direct sequencing.</s><s>As shown in Figure <ref type="figure">4E</ref>, we could detect a clonal Ighv1-26, Ighd2-12, Ighj4 rearrangement.</s><s>The sequence shows an in-frame rearrangement with mutations but no stop-codons.</s><s>Thus, this rearrangement is potentially functional.</s><s>Next, we cloned the amplified Ighv gene rearrangements from this sample and sequenced 32 subclones to investigate intraclonal diversity.</s><s>All analyzed sequences shared 5 mutations compared with the most homologous germ line sequence (Ighv1-26).</s><s>Further mutations could be detected in several subclones (Figure <ref type="figure">4E</ref>), demonstrating intraclonal diversity for this analyzed case.</s></p><p><s>Next, we used immunohistochemistry to further characterize the lymphomas isolated from M-B-Cd19 mice.</s><s>As shown in Figure <ref type="figure">4G</ref> and supplemental Figure <ref type="figure">8</ref>, the lesions stained uniformly positive for Irf4 and were entirely negative for Bcl6, consistent with the somatic hypermutation detected in Figure <ref type="figure">4E</ref> and further corroborating the post-germinal center (GC) nature of the infiltrates. <ref type="bibr" target="#b24">24</ref></s><s>]<ref type="bibr" target="#b39">[39]</ref> In agreement with constitutive NF-kB activation, which is typically observed in human ABC-DLBCL, we found almost exclusive nuclear p65 staining in the lymphomas detected in M-B-Cd19 mice (Figure <ref type="figure">4H</ref>).</s></p><p><s>1]<ref type="bibr" target="#b42">[42]</ref> However, despite considerable effort, we were unable to detect a plasma cell expansion in the bone marrow of M-Cd19, M-Aid, M-Cd21, and M-B-Cd19 mice.</s><s>More importantly, we did not find lymphoma infiltration of the bone marrow in M-Cd19, M-Aid, and M-Cd21 mice, and only 1 of 4 M-B-Cd19 mice showed an isolated lymphoma infiltrate that did not display signs of plasmacellular differentiation (supplemental Figures <ref type="figure">3 and 9</ref>).</s><s>In line with a lack of a consistent bone marrow infiltration, which is an obligatory feature of Waldenström macroglobulinemia and is frequently observed in multiple myeloma, we did not detect monoor oligoclonal gammopathy in either M-Cd19 or M-B-Cd19 mice (supplemental Figure <ref type="figure">10</ref>).</s><s>However, we did detect an increased abundance of the Ig fraction in M-Cd19 mice compared with wildtype controls by using serum electrophoresis (upper and middle panels of supplemental Figure <ref type="figure">10</ref>).</s><s>This gammopathy was even more prominent in M-B-Cd19 mice (lower panel of supplemental Figure <ref type="figure">10</ref>).</s><s>The overall polyclonality strongly suggests a nonneoplastic origin of the gammopathy observed in M-Cd19 and M-B-Cd19 mice.</s><s>Thus in summary, the morphologic appearance, as well as the immunophenotype of the lesions observed in M-B-Cd19 mice strongly suggests that these lymphomas represent ABC-DLBCL.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Here, we generated a novel conditional Myd88 p.L252P allele, which is at the orthologous position of the human Myd88 p.L265P mutation and is expressed from the endogenous locus upon Cre-mediated recombination.</s><s>We chose to design an allele that allows expression outside the natural genomic context to most faithfully mimic the situation in human malignancies.</s><s>B cell-specific expression of this mutant leads to an LPD and occasional (;30%) transformation into an aggressive lymphoma that morphologically and immunophenotypically resembles human ABC-DLBCL.</s><s>Interestingly, development of LPD and lymphoma occurred at a similar rate, regardless of the Cre allele.</s><s>We specifically used a pan B-cell Cre allele (Cd19 Cre ), a Cre allele that is active in GCB cells (Aid Cre ), and a Cre allele that is expressed when immature transitional B cells differentiate into mature peripheral B cells (Cd21 Cre ).</s><s>These data might indicate that Myd88 p.L252P expression leads to a block in B-cell differentiation after the GC reaction.</s><s>Consistent with this postgerminal nature of Myd88 p.L252P -expressing cells, we find that the resulting lymphomas are consistently Bcl6 negative and express Irf4 (Figure <ref type="figure">2E</ref>; supplemental Figure <ref type="figure">1F-G</ref>).</s><s>43]<ref type="bibr" target="#b44">[44]</ref><ref type="bibr" target="#b45">[45]</ref> Furthermore, crossing in an additional allele that allows conditional BCL2 expression from the Rosa26 locus leads to 100%-penetrant development of ABC-DLBCL.</s></p><p><s>Both MYD88 <ref type="bibr" target="#b46">[46]</ref><ref type="bibr" target="#b47">[47]</ref><ref type="bibr" target="#b48">[48]</ref> and BCL2 <ref type="bibr" target="#b24">24,</ref><ref type="bibr" target="#b49">[49]</ref><ref type="bibr" target="#b50">[50]</ref><ref type="bibr" target="#b51">[51]</ref> have been shown to be critical for transition through the GC.</s><s>Thus, it is conceivable that mice displaying B-cell-specific Myd88 p.L252P expression (M-Cd19) or Myd88 p.L252P expression in combination with BCL2 overexpression (M-B-Cd19) might accumulate post-GCB cells.</s><s>Consistent with this, we find a polyclonal gammopathy in both M-Cd19 and M-B-Cd19 mice (supplemental Figure <ref type="figure">10</ref>).</s></p><p><s>MYD88 is frequently mutated in ;29% of ABC-DLBCL cases. 9</s><s>However, MYD88 mutations are even more common in Waldenström macroglobulinemia, in which these alterations are detected in ;90% of the cases. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b52">52</ref></s><s>Thus, it is somewhat surprising that our Myd88 p.L252Pexpressing mice develop clonal ABC-DLBCL rather than Waldenström macroglobulinemia.</s><s>One possible explanation might be the different genomic landscapes of these distinct B-cell neoplasias.</s><s>For instance, mutations in the carboxyl terminal domain of the chemokine receptor CXCR4 have been detected in a substantial portion of patients with Waldenström macroglobulinemia (;30% of the patients), whereas they are absent in ABC-DLBCL. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b53">53</ref></s><s>Furthermore, somatic mutations affecting CD79A and CD79B are present in ;20% of human ABC-DLBCLs, whereas these alterations are rare or absent in other lymphoma entities. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b24">24</ref></s><s>Thus, it will be interesting to combine our novel Myd88 p.L252P allele with additional B-cell-specific genetic alterations to determine whether further manipulation might enable a plasmacytoid differentiation.</s></p><p><s>Our novel models represent a preclinical platform that could be exploited for the in vivo development and validation of novel therapeutic approaches to treat ABC-DLBCL, which remains a difficult-to-treat clinical entity. <ref type="bibr" target="#b54">54,</ref><ref type="bibr" target="#b56">55</ref></s><s>For instance, it will be interesting to see whether combined targeting of the apoptotic machinery and the myddosome, through BCL2 inhibition and IRAK4 repression, will result in synergistic toxicity in Myd88-driven ABC-DLBCL. <ref type="bibr" target="#b56">55</ref></s><s>Our models might also serve to delineate the potential role of NF-kB and MAPKK6 signaling as actionable pathways downstream of the myddosome complex in ABC-DLBCL. <ref type="bibr" target="#b57">56</ref></s><s>For this purpose, it will be interesting to assess the cytotoxic potential of TAK1, IkB kinase, and MAPKK6 inhibitors in our Myd88-driven models of ABC-DLBCL.</s><s>Altogether, we demonstrated the oncogenic role of a novel Myd88 p.L252P allele in B-cell neoplastic disease in vivo.</s><s>The resulting autochthonous mouse models of ABC-DLBCL represent useful preclinical tools for the development, validation, and refinement of novel treatment strategies for ABC-DLBCL in the clinical arena.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Myd88 conditional knock-in allele (after Flp recombination) Myd88 c-p.L252P/c-p.L252P Myd88 c-p.L252P/c-p.L252P M y d 8 8 c -p .</s><s>L 2 5 2 P / c -p .</s><s>L 2 5 2 P</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 1 .Figure 2 .</head><label>12</label><figDesc><div><p><s>Figure 1.</s><s>Construction of a conditional Myd88 p.L252P allele.</s><s>(A) Targeting of the Myd88 locus in C57BL/6N Tac ES cells.The endogenous Myd88 locus was targeted with the linearized vector described in the supplemental Data.</s><s>The targeted allele before (middle panel) and after Flp-mediated recombination of FRT and F3 sites (bottom panel) is schematically depicted.</s><s>The Southern blots of BauI, Eco91I, and KpnI digested genomic DNA probed with a 59, a 39, and a Neo probe, respectively, are shown below the schematic illustration of the targeting strategy.</s><s>Positions of restriction sites and probes are shown in the schematic drawing above.</s><s>(B) Myd88 p.L252P mRNA is expressed upon Cre-mediated recombination in MEFs.</s><s>Myd88 wt/wt and Myd88 c-p.L252P/c-p.L252P MEFs were isolated.</s><s>RNA was isolated from both cell lines before LentiCre application (Sanger sequencing chromatograms, top and middle panels) and the Myd88 mRNA sequence was determined after reverse transcription.</s><s>The wild-type sequence was recovered from both cell lines.</s><s>After LentiCre application and puromycin selection, only the p.L252P sequence could be recovered from Myd88 c-p.L252P/c-p.L252P MEFs (Sanger sequencing chromatogram, bottom panel).</s><s>(C) The Myd88 p.L252P isoform is expressed in Myd88 c-p.L252P/c-p.L252P MEFs after LentiCre-mediated recombination.</s><s>Myd88 wt/wt and Myd88 c-p.L252P/c-p.L252P MEFs were LentiCre exposed and puromycin selected, as in (B).</s><s>Whole-cell lysates were separated on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and blotted onto polyvinylidene difluoride membranes before Myd88 and b-actin, which served as loading controls, and were visualized by immunoblotting.</s><s>Both Myd88 wt and Myd88 p.L252P proteins were expressed at equal levels.</s><s>(D) Conditional LentiCre-mediated Myd88 p.L252P expression leads to p65 Ser-536 phosphorylation.</s><s>Myd88 wt/wt and Myd88 c-p.L252P/c-p.L252P MEFs were transduced with LentiCre and puromycin selected, as in (B).</s><s>Upon selection, cells were lysed, proteins were separated on SDS-PAGE, and pSer-536 p65 was visualized by immunoblot.</s><s>SAH, short arm of homology; LAH, long arm of homology; pA, polyadenylation signal sequence.</s></p></div></figDesc><graphic coords="3,423.35,419.01,79.57,52.46" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .Figure 4 .</head><label>34</label><figDesc><div><p><s>Figure 3. MYD88 mutations and high expression of BCL2 are enriched in ABC-DLBCL.</s><s>(A) MYD88 mutations are substantially enriched in human ABC-DLBCL.</s><s>Human DLBCLs were stratified as ABC-or GCB-DLBCL following the Hans algorithm, as depicted in (B).</s><s>After immunohistochemistry-based stratification, DNA was isolated from tissue sections and subjected to targeted deep sequencing by a multiplex PCR, which covered the ATM, BTK, CD79B, DDX3X, FBXW7, MAPK1, MYD88, NOTCH1, PIK3CA, PIK3CD, PTEN, PTPN6, SF3B1, TP53, and XPO1 genes.</s><s>MYD88 mutations per se, and particularly the MYD88 p.L265P mutation were substantially enriched in ABC-DLBCL.</s><s>Similarly, CD79B and PTEN mutations were enriched in ABC-DLBCL.</s><s>(C) Distribution of MYD88 mutations detected in human DLBCL samples is shown in pie charts.</s><s>The samples were classified into high and low or negative expression of BCL2, as shown in (D).</s><s>(E) High protein expression levels of BCL2 are significantly enriched in ABC-DLBCL (Fisher's exact test).</s></p></div></figDesc><graphic coords="6,80.87,295.77,173.30,116.66" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">BLOOD, 2 JUNE 2016 x VOLUME 127, NUMBER 22 Downloaded from http://ashpublications.org/blood/article-pdf/127/22/2732/1393725/2732.pdf by guest on 17 May 2022</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Downloaded from http://ashpublications.org/blood/article-pdf/127/22/2732/1393725/2732.pdf by guest on 17 May 2022</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Myd88 p.L252P LEADS TO DLBCL IN MICE</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors are indebted to their patients, who provided primary material.</s><s>The</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Conflict-of-interest disclosure: The authors declare no competing financial interests.</s></p><p><s>A full list of members and affiliations of the German International Cancer Genome Consortium Molecular Mechanisms in Malignant Lymphoma by Sequencing Project Consortium appears in the supplemental Data.</s></p><p><s>Correspondence: H. Christian Reinhardt, Department I of Internal Medicine, University Hospital of Cologne, Weyertal 115B, 50931 Cologne, Germany; e-mail: christian.reinhardt@uk-koeln.de.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Toll-like receptor signalling</title>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="499" to="511" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Compagno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grunn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">459</biblScope>
			<biblScope unit="issue">7247</biblScope>
			<biblScope unit="page" from="717" to="721" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Loiarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Ruggiero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">42</biblScope>
			<biblScope unit="page" from="30210" to="30222" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">465</biblScope>
			<biblScope unit="issue">7300</biblScope>
			<biblScope unit="page" from="885" to="890" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Distinct molecular mechanism for initiating TRAF6 signalling</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Arron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamothe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">418</biblScope>
			<biblScope unit="issue">6896</biblScope>
			<biblScope unit="page" from="443" to="447" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Direct activation of protein kinases by unanchored polyubiquitin chains</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">P</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">461</biblScope>
			<biblScope unit="issue">7260</biblScope>
			<biblScope unit="page" from="114" to="119" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">S</forename><surname>Puente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pinyol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Quesada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">475</biblScope>
			<biblScope unit="issue">7354</biblScope>
			<biblScope unit="page" from="101" to="105" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">MYD88 L265P somatic mutation in Waldenström&apos;s macroglobulinemia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Treon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="826" to="833" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Oncogenically active MYD88 mutations in human lymphoma</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Ngo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schmitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">470</biblScope>
			<biblScope unit="issue">7332</biblScope>
			<biblScope unit="page" from="115" to="119" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">B lymphocytespecific, Cre-mediated mutagenesis in mice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Rickert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1317" to="1318" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Robbiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bothmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Callen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1028" to="1038" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kraus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Alimzhanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rajewsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajewsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="787" to="800" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumors</title>
		<author>
			<persName><forename type="first">A</forename><surname>Riabinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Herter-Sprie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">189</biblScope>
			<biblScope unit="page" from="189" to="178" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bichi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Shinton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="6955" to="6960" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Dissecting p53 tumor suppressor functions in vivo</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Fridman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Baranov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Lowe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="289" to="298" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Mechanisms of intracerebral lymphoma growth delineated in a syngeneic mouse model of central nervous system lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Montesinos-Rongen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brunn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="325" to="336" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">IMGT, the international ImMunoGeneTics information system</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Lefranc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Giudicelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ginestoux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="D1006" to="D1012" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Regulation of AID expression in the immune response</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Crouch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takizawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1145" to="1156" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Hans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Weisenburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Greiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="275" to="282" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Ngo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lenz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">463</biblScope>
			<biblScope unit="issue">7277</biblScope>
			<biblScope unit="page" from="88" to="92" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">CD79B and MYD88 mutations in diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="556" to="564" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Dierlamm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Murga</forename><surname>Penas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Bentink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">Deutsche Krebshilfe Network</forename><surname>Project</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="688" to="696" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Molecular Mechanisms in Malignant Lymphomas</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Genetic lesions in diffuse large B-cell lymphomas</title>
		<author>
			<persName><forename type="first">M</forename><surname>Testoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zucca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bertoni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1069" to="1080" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Malignant pirates of the immune system</title>
		<author>
			<persName><forename type="first">L</forename><surname>Rui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ceribelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Staudt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="933" to="940" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways</title>
		<author>
			<persName><forename type="first">G</forename><surname>Lenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Emre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">36</biblScope>
			<biblScope unit="page" from="13520" to="13525" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">ICGC MMML-Seq Project. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing</title>
		<author>
			<persName><forename type="first">J</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schlesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1316" to="1320" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">ICGC MMML-Seq project; BLUEPRINT project. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kretzmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Bernhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1316" to="1325" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Alizadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Eisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">403</biblScope>
			<biblScope unit="issue">6769</biblScope>
			<biblScope unit="page" from="503" to="511" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Jeelall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Beutler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Horikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Goodnow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="413" to="426" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Pharmacological and genomic profiling identifies NF-kB-targeted treatment strategies for mantle cell lymphoma</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rahal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Romero</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="87" to="92" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells</title>
		<author>
			<persName><forename type="first">Mathews</forename><surname>Griner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Guha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2349" to="2354" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium</title>
		<author>
			<persName><forename type="first">G</forename><surname>Salles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="7070" to="7078" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">A practical approach to the understanding and diagnosis of lymphoma: an assessment of the WHO classification based on immunoarchitecture and immuno-ontogenic principles</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Tan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathology</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="305" to="326" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Skyrlas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Agnantis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anticancer Res</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1A</biblScope>
			<biblScope unit="page" from="347" to="362" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Dualreactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Fournier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Velez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Leahy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">209</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1797" to="1812" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Coro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Baumgarth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4343" to="4351" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcclintock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Cleveland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="464" to="470" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Colomo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guillermo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Perales</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="78" to="84" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Aggressive B-cell lymphomas: how many categories do we need?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Said</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S42" to="S56" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">L265P mutation of the MYD88 gene is frequent in Waldenström&apos;s macroglobulinemia and its absence in myeloma</title>
		<author>
			<persName><forename type="first">N</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohwashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshinaga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">e80088</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction</title>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">R</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2051" to="2058" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstr öm&apos;s macroglobulinemia</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jim Énez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sebasti Án</surname></persName>
		</author>
		<author>
			<persName><surname>Chill Ón</surname></persName>
		</author>
		<author>
			<persName><surname>Mc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1722" to="1728" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Evolution and impact of subclonal mutations in chronic lymphocytic leukemia</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Landau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Stojanov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="714" to="726" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Mutations driving CLL and their evolution in progression and relapse</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Landau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tausch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Taylor-Weiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">526</biblScope>
			<biblScope unit="issue">7574</biblScope>
			<biblScope unit="page" from="525" to="530" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia</title>
		<author>
			<persName><forename type="first">V</forename><surname>Quesada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Conde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Villamor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="47" to="52" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lamagna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">192</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="875" to="885" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Saudan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="375" to="384" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">B cell intrinsic TLR signals amplify but are not required for humoral immunity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Meyer-Bahlburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Rawlings</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="3095" to="3101" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Novak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Piovan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="11294" to="11299" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Polo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cerchietti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="5536" to="5548" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Light</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>O'reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tarlinton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="475" to="484" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Waldenström macroglobulinemia: What a hematologist needs to know</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kapoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Paludo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vallumsetla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Greipp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Rev</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="301" to="319" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">R</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1637" to="1646" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">ESMO Guidelines Committee. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gomes Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Vitolo</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>treatment and follow-up</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="116" to="125" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Romero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="2189" to="2201" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Pattern recognition receptors and inflammation</title>
		<author>
			<persName><forename type="first">O</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Akira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="805" to="820" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
